With ongoing research, collaboration, and advocacy, we move closer to a future where brain cancer is no longer a devastating diagnosis but a manageable condition ... Mar 09
The abnormal development of brain cells, which can be benign or metastatic, is known as a brain tumor. Because of their essential position, brain tumors ... Jun 08
BYVASDA is an anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody and a bevacizumab biosimilar independently developed by Innovent Biologics... Dec 28
... Dec 23
CNS Pharma will initiate its trial during the first quarter of 2021 to investigate the efficacy of Berubicin in adults with GBM who have failed ... Dec 18
LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
Researchers will present new data supporting the Xoft System for the treatment of early-stage breast cancer and gynecological cancers.... Oct 24
WindMIL Therapeutics and Stephenson Cancer Center announce collaboration to collect bone marrow from patients with renal and urothelial carcinomas ... Oct 14
PharmAbcine is a clinical-stage biotech company developing fully human therapeutic antibodies to treat cancer and neovascular disease... Sep 22
City of Hope enters licensing agreement with Chimeric Therapeutics Limited to develop its pioneering chlorotoxin CAR T Cell therapy ... Sep 22
Plus Therapeutics receives fast track designation from FDA for its novel glioblastoma treatment ... Sep 16
Binex will produce olinvacimab at its new 5,000L production line... Sep 03
Northwest Biotherapeutics, a biotechnology company today announced that the Company has acquired Flaskwork... Sep 02
PharmAbcine signs long-term contract manufacturing organization agreement for Olinvacimab with Binex ... Jun 27
WORLD BRAIN TUMOR DAY: New-age treatments are boosting survivals rates in the youngest victims of brain cancer ... Jun 06
Biocon and Mylan’s proposed biosimilar bevacizumab is expected to be the third biosimilar from the partnered portfolio for the cancer patients in the U.... Mar 12
-Advertisements-